Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Majalin Capital

VC INVESTOR TYPE
Active STATUS
4 PROFESSIONALS
12 INVESTMENTS
6 PORTFOLIO
8 EXITS
Description

Majalin Capital is an investment firm that prefers to make both venture capital and growth equity investments in the healthcare sector including therapeutics, devices, diagnostics and services. The firm is based in New York, New York.

Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Primary Office
  • 295 Madison Avenue
  • 32nd Floor
  • New York, NY 10017
  • United States

+1 (212) 000-0000

Majalin Capital Investments (12)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
MIACH Orthopaedics 17-Sep-2018 Early Stage VC 000.00 Surgical Devices Stealth
000 000000 16-May-2018 0000 0000 Biotechnology Profitable
00000 000000000000 05-Apr-2018 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2
000000 00000000000 16-Feb-2018 00000 00000 000.00 Drug Discovery Clinical Trials - General
000 (0000000000000 28-Sep-2017 0000 000.00 Biotechnology Generating Revenue
0000000 0000000 00 07-Nov-2016 00000 00000 000.00 Therapeutic Devices Generating Revenue 00000 00000
000000000 0000000 14-Sep-2016 00000 00000 000.00 Surgical Devices Generating Revenue 00000 00000
0000000 0000000000 08-Sep-2015 00000 00000 0000 Drug Discovery Clinical Trials - General
KEW 12-Jan-2015 Later Stage VC 000.00 Biotechnology Generating Revenue 00000 00000
Zosano Pharma 04-Dec-2014 Convertible Debt 00.00 Drug Delivery Generating Revenue
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Majalin Capital’s full profile, request a free trial.

Majalin Capital Exits (7)

Company Name Exit Date Exit Type Exit Size Status Buyers
Eidos Therapeutics 21-Jun-2018 IPO 00000 Completed
0000000 0000000 00 03-May-2018 000 00000 Completed
000000 000000 29-Mar-2018 000000 0000000000 0000 Completed
0000000 0000000000 22-Jun-2016 000 0000 Completed
0000 0000000 11-Jan-2016 0000000000 Completed
  • 4 buyers
Teligent 31-Dec-2015 Secondary Transaction - Open Market Completed
Zosano Pharma 26-Jan-2015 IPO 000.00 Completed
To view this investor’s complete exits history, request access »

Majalin Capital Team (5)

Name Title Deals Funds Boards Office Contact
Info
Anders Hove MD Managing Partner 00 00 0 New York, NY
Uya Chuluunbaatar Ph.D Vice President New York, NY
Max Lewin Associate New York, NY
Joyce Erony Managing Partner 00 0 0 New York, NY

1 Former Team Member

You’re viewing 4 of 5 team members. Get the full list »